COLLAGENEX PHARMACEUTICALS INC 4
4 · COLLAGENEX PHARMACEUTICALS INC · Filed Aug 13, 2007
Insider Transaction Report
Form 4
BROADBENT NANCY C
CFO and Treasurer
Transactions
- Exercise/Conversion
Option to purchase common stock
2007-08-09−8,333→ 282,967 totalExercise: $6.25Exp: 2008-02-11→ Common Stock (8,333 underlying) - Exercise/Conversion
Common Stock
2007-08-09$6.25/sh+8,333$52,081→ 60,208 total - Sale
Common Stock
2007-08-09$13.25/sh−80$1,060→ 60,128 total - Sale
Common Stock
2007-08-09$13.25/sh−8,253$109,352→ 51,875 total
Footnotes (3)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 23, 2007.
- [F2]Represents partial exercise of an option to purchase an aggregate of 25,000 shares granted by the Issuer pursuant to its 1996 Stock Option Plan on February 12, 1998. Such option vested as follows: 5,000 shares subject to such option vested on February 12, 1999, 5,000 shares subject to such option vested on February 12, 2000, 5,000 shares subject to such option vested on February 12, 2001, 5,000 shares subject to such option vested on February 12, 2002 and 5,000 shares subject to such option vested on February 12, 2003.
- [F3]Includes multiple option grants with different prices and vesting dates.